Pharmacology and Clinical Potential of Direct Thrombin Inhibitors

E-ISSN： 1873-4286|11|30|3877-3884

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.30, 2005-11, pp. : 3877-3884

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of Venous Thromboembolism Following Orthopaedic Surgery: Clinical Potential of Direct Thrombin Inhibitors

By Eriksson B.I.

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 577-595

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology of Direct and Indirect Factor Xa Inhibitors

By Rupprecht Hans-Juergen Blank Ralf

Drugs, Vol. 70, Iss. 16, 2010-11 ,pp. : 2153-2170

Adis International

Access to resources Recommend Favorite

Direct thrombin inhibitors

By Kaplan Karen L

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite

Small-molecule direct thrombin inhibitors

By Wiley M.R. Fisher M.J.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 11, 1997-11 ,pp. : 1265-1282

Informa Healthcare

Access to resources Recommend Favorite

Squalene Synthase Inhibitors: Clinical Pharmacology and Cholesterol-Lowering Potential

By Charlton-Menys Valentine Durrington Paul N.

Drugs, Vol. 67, Iss. 1, 2007-01 ,pp. : 11-16

Adis International

Access to resources Recommend Favorite